Phenotypical analysis, relation to malignancy and prognostic relevance of ICOS+T regulatory and dendritic cells in patients with gliomas
- 1 November 2013
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 264 (1-2), 84-90
- https://doi.org/10.1016/j.jneuroim.2013.09.001
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control studyBMC Cancer, 2011
- Frequent abnormalities of the immune system in gliomas and correlation with the WHO grading system of malignancyJournal of Neuroimmunology, 2010
- Regulatory T cells: immune suppression and beyondCellular & Molecular Immunology, 2010
- Regulatory T Cells in CancerPublished by Elsevier ,2010
- The Role of Tregs in Glioma-Mediated Immunosuppression: Potential Target for InterventionNeurosurgery Clinics of North America, 2009
- Recent Advances of Dendritic Cells (DCs)-Based Immunotherapy for Malignant GliomasCell Transplantation, 2009
- Cortisol and epinephrine control opposing circadian rhythms in T cell subsetsBlood, 2009
- Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human GliomasClinical Cancer Research, 2008
- Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and PeripheryImmunity, 2008
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000